HNF-3α, commonly known as Hepatocyte Nuclear Factor 3-alpha, is a member of the forkhead box (FOX) family of transcription factors. These transcription factors are characterized by a distinct DNA-binding forkhead domain and play vital roles in regulating the expression of genes involved in various cellular processes. HNF-3α, specifically known as FOXA1 in modern nomenclature, has been identified to play a pivotal role in the development and differentiation of the liver, lung, and pancreas. It acts as a pioneer factor, which means it can bind to compacted chromatin in its native state and open it up, allowing other transcription factors to bind and initiate transcription. FOXA1, by virtue of its ability to regulate gene expression, has a profound influence on cellular differentiation, metabolism, and homeostasis in the tissues where it is active.
HNF-3α Activators, in the realm of molecular biology and biochemistry, are compounds or molecules aimed at enhancing the transcriptional activity of the HNF-3α protein. By potentiating the action of HNF-3α, these activators would promote the expression of genes that are under the control of this transcription factor. The activation of HNF-3α could lead to enhanced differentiation and metabolic activity in cells of the liver, lung, and pancreas. The design and identification of HNF-3α activators would likely involve a comprehensive understanding of the protein's structure, DNA-binding dynamics, and interactions with co-factors and other regulatory elements. The ability to modulate the activity of such a pivotal transcription factor opens up avenues for understanding cellular differentiation and function at a molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Acts as a pioneer factor for the estrogen receptor, potentially modulating FOXA1 expression in breast tissue. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone Deacetylase inhibitor that can alter chromatin structure, potentially influencing FOXA1 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methylation inhibitor that might affect FOXA1 expression by altering DNA methylation patterns. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences cellular differentiation and development, potentially impacting FOXA1 expression. | ||||||
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $114.00 $286.00 | 2 | |
Given FOXA1's role in liver metabolism, certain fatty acids might influence its expression. | ||||||
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
As FOXA1 plays a role in hepatic glucose metabolism, factors influencing glucose might modulate FOXA1 expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Potential modulation of FOXA1 expression in the context of hepatic glucose metabolism. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
A fatty acid that might modulate FOXA1 expression given its metabolic implications and effects on transcriptional activity. | ||||||